[Pathophysiologic basis for increasing the hemodynamic effectiveness of plasma substitutes].
D000818:Animals; D001802:Blood Substitutes / Q000008:administration & dosage*; D003911:Dextrans / Q000008:administration & dosage; D006439:Hemodynamics / Q000187:drug effects*; D008297:Male; D009285:Naphthoquinones / Q000008:administration & dosage*; D011817:Rabbits; D012771:Shock, Hemorrhagic / Q000503:physiopathology*
D001802:Blood Substitutes; D003911:Dextrans; D009285:Naphthoquinones; C035342:1,4-naphthoquinone
Patofiziologicheskie osnovy povysheniia éffektivnosti krovezameniteleĭ gemodinamicheskogo deĭstviia.